Literature DB >> 27196071

Intraoperative radiation therapy as adjuvant treatment in locally advanced stage tumours involving the middle ear: a hypothesis-generating retrospective study.

G Cristalli1, G Mercante1, L Marucci2, A Soriani3, S Telera4, G Spriano1.   

Abstract

The objective of this study was to evaluate the safety, effectiveness and functional outcomes of intraoperative radiotherapy (IORT) followed by intensity-modulated radiation therapy (IMRT) in locally advanced stage tumours involving the middle ear. Data on 13 consecutive patients treated for malignant tumor of external auditory canal involving the middle ear were retrospectively reviewed. Median follow-up was 33 months (range 6-133). Five (38%) patients were stage III and 8 (62%) were Stage IV according to the University of Pittsburgh staging system. Lateral temporal bone resection (LTBR) was performed in all cases. LTBR was associated with parotidectomy in 5 (38%) cases, and with neck dissection and parotidectomy in 6 (46%) cases. No patients had gross residual tumour. Surgical treatment was followed by IORT (12 Gy) and IMRT (50 Gy). Adjuvant chemotherapy was used in 4 (30%) cases. Preoperative and postoperative audiometric tests were performed to assess hearing loss. 5-year local-control (LC), 5-year distant-metastasis (DM), 5-year disease-free-survival (DFS) and 5-year overall-survival (OS) were calculated with Kaplan-Meyer method. Significant changes in bone conduction were reported after treatment. Partial flap necrosis was the only early complication observed in three (23%) cases, while meningeal fistula was seen in one (7.6%) case as a late complication. The 5-year LC-rate was 68%. The 5-year DM-rate was 90%. The 5-year DFS-rate was 61%. The 5-year OS-rate was 69%. IORT followed by IMRT for the treatment of advanced external auditory canal and middle ear tumours seems to be safe. No intraoperative death was reported. IORT may reduce the postoperative irradiation of remnant tissue obtaining the same full dose on the tumour bed. No complications of the residual external ear were observed. Detriment of neurosensory hearing may be expected. Future studies are required to confirm the benefit of this procedure in the ear. © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.

Entities:  

Keywords:  Ear tumours; Hearing loss; IORT; Intraoperative radiotherapy; Middle ear cancer; Toxicity

Mesh:

Year:  2016        PMID: 27196071      PMCID: PMC4907165          DOI: 10.14639/0392-100X-486

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  17 in total

1.  Osteoradionecrosis of the skull after radiation therapy for invasive carcinoma.

Authors:  Michaela T Nguyen; Alicia Billington; Mutaz B Habal
Journal:  J Craniofac Surg       Date:  2011-09       Impact factor: 1.046

2.  Setup verification and in vivo dosimetry during intraoperative radiation therapy (IORT) for prostate cancer.

Authors:  Antonella Soriani; Valeria Landoni; Simona Marzi; Giuseppe Iaccarino; Biancamaria Saracino; Giorgio Arcangeli; Marcello Benassi
Journal:  Med Phys       Date:  2007-08       Impact factor: 4.071

3.  Long-term outcomes of facial nerve function in irradiated and nonirradiated nerve grafts.

Authors:  Samuel C Leong; Tristram H Lesser
Journal:  Ann Otol Rhinol Laryngol       Date:  2013-11       Impact factor: 1.547

4.  Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings.

Authors:  M Arriaga; H Curtin; H Takahashi; B E Hirsch; D B Kamerer
Journal:  Ann Otol Rhinol Laryngol       Date:  1990-09       Impact factor: 1.547

5.  Carcinoma of the external auditory canal and middle ear.

Authors:  L Pfreundner; K Schwager; J Willner; K Baier; K Bratengeier; F X Brunner; M Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-01       Impact factor: 7.038

6.  Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases.

Authors:  Umberto Veronesi; Roberto Orecchia; Alberto Luini; Viviana Galimberti; Giovanna Gatti; Mattia Intra; Paolo Veronesi; Maria Cristina Leonardi; Mario Ciocca; Roberta Lazzari; Pietro Caldarella; Serife Simsek; Luzemira Santos Silva; Daniele Sances
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

7.  Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases.

Authors:  M Kusters; V Valentini; F A Calvo; R Krempien; G A Nieuwenhuijzen; H Martijn; G B Doglietto; E Del Valle; F Roeder; M W Buchler; C J H van de Velde; H J T Rutten
Journal:  Ann Oncol       Date:  2009-11-04       Impact factor: 32.976

8.  Squamous cell carcinoma involving the temporal bone: lateral temporal bone resection as primary intervention.

Authors:  Amy Anne D Lassig; Matthew E Spector; Soheil Soliman; Hussam K El-Kashlan
Journal:  Otol Neurotol       Date:  2013-01       Impact factor: 2.311

9.  Guidelines for treating temporal bone carcinoma based on long-term outcomes.

Authors:  Andrea Bacciu; Ignazio Alessandro Clemente; Enrico Piccirillo; Silvano Ferrari; Mario Sanna
Journal:  Otol Neurotol       Date:  2013-07       Impact factor: 2.311

Review 10.  Normal tissue tolerance to intraoperative radiotherapy.

Authors:  William F Sindelar; Timothy J Kinsella
Journal:  Surg Oncol Clin N Am       Date:  2003-10       Impact factor: 3.495

View more
  1 in total

Review 1.  Treatment Strategies for Malignancies of the External Auditory Canal.

Authors:  Shixun Zhong; Wenqi Zuo
Journal:  Curr Treat Options Oncol       Date:  2022-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.